Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
Walsh
P
P
Department of Dermatology, University of Colorado School of Medicine, Denver 80262.
Aeling
J L
JL
Huff
L
L
Weston
W L
WL
D001623:Betamethasone / Q000009:adverse effects / Q000031:analogs & derivatives*; D002990:Clobetasol / Q000009:adverse effects / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008297:Male; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy* / Q000652:urine
C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; C064466:halobetasol; D002990:Clobetasol; D006854:Hydrocortisone